The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200415047089N1

Enrollment

100

Registered

2020-04-19

Start date

2020-04-18

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID 19. U07.1

Interventions

Intervention group: In this study, 2 herbal medicines (in addition to standard treatment) will be used as follows. 1. Vomigone 500 tablets (containing ginger) 2 TDS a day (after meals) With drug regi

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: suspected COVID-19 outpatient cases according to the flowchart for the Diagnosis and Treatment of 19 COVID Diseases of the Ministry of Health, Age between 18 and 65 years, Signing a Informed Consent

Exclusion criteria

Exclusion criteria: Pregnancy, Breastfeeding, history of drug allergy, complications of bacterial infection, underlying diseases (heart disease, renal failure, liver failure, primary vascular and cardiovascular disease, chronic lung disease, malignancy, endocrine and metabolic diseases, thyroid disorders) Immune system defects, encephalopathy, neuropathy

Design outcomes

Primary

Measure	Time frame
Improvement of clinical symptoms. Timepoint: Start of study and 7 days after study. Method of measurement: Questionnaire - telephone follow-up and.	—

Secondary

Measure	Time frame
Hospitalizations. Timepoint: 7 and 14 days after study. Method of measurement: Telephone follow up.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmehdi mesri

Saveh University of Medical Sciences

mesrimd@gmail.com+98 86 4222 4414

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026